OCS
Oculis Holding AG
NASDAQ · Healthcare · Biotechnology · CH
$12.17
+0.00%Institutional positioning
13F filings over the trailing two quarters
New 23Increased 12Reduced 11Sold out 55
| Filer | Action | Shares | Filed |
|---|---|---|---|
| EQT FUND MANAGEMENT S.A R.L. | Unchanged | 5,900,294 | May 14, 2026 |
| Gildi - lifeyrissjodur | Reduced | 2,430,401 | Apr 14, 2026 |
| ABRDN PLC | Unchanged | 1,746,946 | Apr 29, 2026 |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | Reduced | 1,680,283 | May 14, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 1,345,728 | May 15, 2026 |
| CITADEL ADVISORS LLC | Increased | 1,031,604 | Sep 2, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 913,034 | May 15, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | New Position | 833,209 | May 15, 2026 |
| SR ONE CAPITAL MANAGEMENT, LP | Unchanged | 641,022 | May 14, 2026 |
| SATURN V CAPITAL MANAGEMENT LLC | Unchanged | 516,761 | May 15, 2026 |
| PERCEPTIVE ADVISORS LLC | Unchanged | 493,827 | May 29, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | New Position | 430,000 | May 15, 2026 |
| NAN FUNG GROUP HOLDINGS LTD | Reduced | 350,745 | May 14, 2026 |
| ALYESKA INVESTMENT GROUP, L.P. | Unchanged | 331,332 | May 15, 2026 |
| FOLKETRYGDFONDET | Increased | 319,556 | May 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings